GO:0045860 positive regulation of protein kinase activity: Signaling Amplification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045860 describes any biological process that activates or increases the frequency, rate, or extent of protein kinase activity, making it a central node in signal transduction.
• Positive regulation of protein kinase activity is achieved through diverse mechanisms including phosphorylation, subunit assembly, ubiquitin-proteasome remodeling, and metabolite-driven modification.
• Key kinases such as AMPK, MAPK, mTOR, and NME7 are regulated by this process, linking it to metabolism, autophagy, cell survival, and cancer.
• Dysregulation of positive regulation of protein kinase activity contributes to cancer, metabolic disorders, and neurological disease, making it a major therapeutic target.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential for dissecting causal roles of kinases and their regulators in this process.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study positive regulation of protein kinase activity at scale.
Description
Protein kinases are enzymes that transfer phosphate groups from ATP to protein substrates, and their activity must be tightly controlled to maintain cellular homeostasis. GO:0045860, positive regulation of protein kinase activity, refers to any process that activates or increases the frequency, rate, or extent of protein kinase activity. This ontology term captures a broad set of molecular events, from allosteric activation and subunit assembly to post-translational modifications and degradation of inhibitory proteins, that ultimately enhance kinase function. Understanding this process is fundamental because kinases sit at the heart of nearly every signaling pathway, and their inappropriate activation drives diseases such as cancer, diabetes, and neurodegeneration. Research into positive regulation of protein kinase activity has revealed that it is not a single mechanism but a convergence of multiple regulatory layers. For example, AMP-activated protein kinase (AMPK) activity is positively regulated by its noncatalytic beta and gamma subunits, which modulate its response to cellular energy stress. Similarly, the ubiquitin-proteasome system can either stabilize or degrade kinases and their regulators, thereby fine-tuning mitogen-activated protein kinase (MAPK) signaling. More recently, lactylation of mTOR has been shown to enhance autophagy in skeletal muscle during exercise, illustrating how metabolic modifications can directly boost kinase activity. These examples highlight the diversity of positive regulatory inputs that converge on protein kinases. For researchers, GO:0045860 provides a conceptual framework to annotate and interpret experiments involving kinase activation. Whether studying cancer cell proliferation, metabolic adaptation, or neuronal signaling, the ability to define and manipulate positive regulation of protein kinase activity is critical for identifying therapeutic targets and understanding disease mechanisms. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of the term, its mechanisms, key genes, and experimental approaches.
positive regulation of protein kinase activity At A Glance
| GO ID | GO:0045860 |
|---|---|
| GO term | positive regulation of protein kinase activity |
| Ontology | biological_process |
| Synonym | stimulation of protein kinase activity; up regulation of protein kinase activity; up-regulation of protein kinase activity; upregulation of protein kinase activity |
| Major function | Activates or increases the frequency, rate, or extent of protein kinase activity |
| Related cellular process | Signal transduction, metabolism, autophagy, cell cycle, stress response |
| Example regulators | AMPK subunits, MAPK pathway components, mTOR, NME7, ubiquitin-proteasome system |
| Disease relevance | Cancer, metabolic disorders, neurological diseases, inflammation |
What Is GO:0045860?
Positive regulation of protein kinase activity (GO:0045860) is defined as any biological process that activates or increases the frequency, rate, or extent of protein kinase activity. In other words, it encompasses all molecular events that lead to a net increase in the ability of a protein kinase to phosphorylate its substrates. This regulation can occur through direct modification of the kinase itself, interaction with regulatory subunits, changes in subcellular localization, or modulation of inhibitory factors. The term is a biological process and is distinct from the intrinsic kinase activity itself (molecular function), focusing instead on the regulatory inputs that enhance that activity.
Why Is positive regulation of protein kinase activity Important in Cell Biology?
Positive regulation of protein kinase activity is a cornerstone of cellular signaling because it determines how cells respond to hormones, growth factors, nutrients, and stress. Dysregulation of this process is implicated in a wide range of human diseases, including cancer, where hyperactive kinases drive uncontrolled proliferation, and metabolic disorders such as diabetes, where AMPK regulation is critical for insulin sensitivity. Understanding the mechanisms that positively regulate kinase activity provides opportunities for therapeutic intervention, as many drugs target kinases or their upstream regulators. Moreover, this GO term helps researchers systematically annotate and compare experimental data across different signaling contexts.
• Central to signal transduction pathways that control cell growth, differentiation, and survival.
• Critical for metabolic adaptation through AMPK activation in response to energy stress.
• Involved in autophagy regulation via mTOR lactylation during exercise.
• Plays a key role in cancer progression, including hepatocellular carcinoma through NME7-mediated Wnt/beta-catenin activation.
• Modulated by the ubiquitin-proteasome system, offering pharmacological targets for MAPK-driven diseases.
• Essential for immune cell activation and inflammatory responses.
• Contributes to neuronal signaling and synaptic plasticity, with implications for neurodegeneration.
• Provides a framework for annotating high-throughput phosphoproteomics data.
• Enables synthetic biology approaches to engineer kinase-based biosensors and circuits.
• Serves as a target for drug discovery, with many kinase inhibitors in clinical use.
What Happens During positive regulation of protein kinase activity?
Upstream Signal Reception and Kinase Activation
In simple terms: A signal from outside or inside the cell triggers a chain of events that turns on a kinase.
Positive regulation of protein kinase activity often begins with an upstream signal, such as a growth factor, hormone, or cellular stress. This signal is received by receptors or sensors that then activate a cascade of kinases. For example, mitogen-activated protein kinase (MAPK) pathways are activated by a series of phosphorylation events that ultimately increase the activity of downstream kinases. Similarly, AMP-activated protein kinase (AMPK) is activated by increases in the AMP/ATP ratio, which is sensed by its gamma subunit. The initial activation step frequently involves conformational changes or post-translational modifications that relieve autoinhibition or promote catalytic activity.
Post-translational Modifications and Allosteric Regulation
In simple terms: Chemical tags or shape changes can directly boost a kinase's ability to work.
Once a kinase is primed, its activity can be further enhanced by post-translational modifications. Phosphorylation of the kinase itself or its regulatory subunits is a common mechanism; for instance, AMPK is phosphorylated by upstream kinases such as LKB1, which increases its activity. Ubiquitination and deubiquitination also play critical roles in regulating MAPK signaling by controlling the stability of pathway components. More recently, lactylation of mTOR has been shown to enhance its activity and promote autophagy in skeletal muscle during exercise, illustrating a novel metabolite-driven modification. These modifications often act allosterically, changing the kinase's conformation to favor substrate binding or catalysis.
Subunit Assembly and Complex Formation
In simple terms: Kinases often need to team up with other proteins to become fully active.
Many protein kinases function as multi-subunit complexes, and positive regulation can involve the assembly or rearrangement of these complexes. AMPK, for example, consists of a catalytic alpha subunit and regulatory beta and gamma subunits; the beta and gamma subunits are essential for regulating AMPK activity in response to energy status. Similarly, the protein-arginine kinase McsB requires the adaptor protein McsA for its regulation, as revealed by structural studies. Complex formation can also bring kinases into proximity with their substrates or with activating enzymes, thereby increasing the effective rate of phosphorylation.
Spatiotemporal Control and Scaffolding
In simple terms: Where and when a kinase is located in the cell can determine whether it gets activated.
Positive regulation of protein kinase activity is also achieved by controlling the localization and timing of kinase action. Scaffold proteins can tether kinases to specific subcellular compartments or to their substrates, enhancing signaling efficiency. For instance, the ubiquitin-proteasome system can regulate the abundance and localization of MAPK pathway components, thereby influencing the duration and strength of kinase signaling. In the context of NME7, its kinase activity activates Wnt/beta-catenin signaling to promote one-carbon metabolism in hepatocellular carcinoma, demonstrating how spatial organization of signaling components contributes to positive regulation.
Feedback and Crosstalk with Other Pathways
In simple terms: The cell has built-in checks and balances that can either boost or dampen kinase activity.
Positive regulation of protein kinase activity does not occur in isolation; it is often modulated by feedback loops and crosstalk with other signaling pathways. For example, AP-1 transcription factors are regulated by MAPK pathways and can in turn influence the expression of kinases and their regulators, creating feedback that shapes cell life and death decisions. AMPK activation can also crosstalk with mTOR signaling, balancing anabolic and catabolic processes. Understanding these feedback mechanisms is crucial for predicting the outcomes of pharmacological or genetic interventions targeting kinase activity.
Key Genes Involved in GO:0045860 positive regulation of protein kinase activity
The following genes and proteins are central to positive regulation of protein kinase activity, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AMPK (PRKAA1/2, PRKAB1/2, PRKAG1/2/3) | Energy sensor kinase complex; beta and gamma subunits regulate activity | Metformin response, insulin sensitivity, exercise metabolism |
| MAPK1/3 (ERK2/1) | Mitogen-activated protein kinases; positively regulated by upstream phosphorylation | Cell proliferation, cancer, ubiquitin-proteasome regulation |
| MTOR | Serine/threonine kinase; lactylation enhances activity during exercise | Autophagy, skeletal muscle metabolism, aging |
| NME7 | Protein kinase that activates Wnt/beta-catenin signaling | Hepatocellular carcinoma, one-carbon metabolism |
| McsB | Protein-arginine kinase regulated by McsA | Bacterial stress response, structural insights |
| JUN | AP-1 transcription factor subunit; downstream of MAPK | Cell life and death decisions, cancer |
| FOS | AP-1 transcription factor subunit; regulated by MAPK | Proliferation, differentiation, apoptosis |
| LKB1 (STK11) | Upstream kinase that phosphorylates and activates AMPK | Metabolic regulation, cancer predisposition |
| UBB | Ubiquitin; tags proteins for proteasomal degradation | Regulation of MAPK pathway components |
| UBC | Ubiquitin; involved in proteasomal degradation | Fine-tuning of kinase signaling |
| PSMD1 | Proteasome subunit; degrades ubiquitinated proteins | Regulation of kinase abundance |
| CTNNB1 | Beta-catenin; downstream effector of NME7 kinase activity | Wnt signaling, hepatocellular carcinoma |
| PRKAA1 | Catalytic alpha-1 subunit of AMPK | Energy homeostasis, autophagy |
| PRKAA2 | Catalytic alpha-2 subunit of AMPK | Metabolic regulation in muscle and liver |
| PRKAB1 | Noncatalytic beta-1 subunit of AMPK | Regulation of AMPK activity |
| PRKAG1 | Noncatalytic gamma-1 subunit of AMPK | AMP/ATP sensing |
| RPS6KB1 | p70S6 kinase; downstream of mTOR | Protein synthesis, cell growth |
| EIF4EBP1 | mTOR substrate; regulates translation initiation | Autophagy, metabolism |
How Is positive regulation of protein kinase activity Regulated?
Positive regulation of protein kinase activity is itself tightly regulated through multiple layers. Upstream kinases such as LKB1 phosphorylate and activate AMPK in response to energy stress. The ubiquitin-proteasome system controls the stability of MAPK pathway components, thereby modulating the duration and intensity of kinase signaling. Metabolic modifications, such as lactylation of mTOR, provide a direct link between cellular metabolism and kinase activation. Additionally, scaffold proteins and subcellular localization determine where and when kinases become active. These regulatory mechanisms ensure that kinase activity is appropriate for the cellular context and can be rapidly adjusted in response to changing conditions.
positive regulation of protein kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NME7 | Hepatocellular carcinoma | Knockout of NME7 in HepG2 cells; Wnt/beta-catenin reporter assay |
| AMPK (PRKAA1) | Type 2 diabetes, metabolic syndrome | Point mutation of Thr172 in PRKAA1 to block activation; insulin sensitivity assays |
| MTOR | Autophagy dysregulation, muscle wasting | Knock-in of lactylation-mimetic mutation in mTOR; exercise mimetic studies |
| MAPK1 | Cancer, inflammatory diseases | Knockout of MAPK1 in cancer cell lines; phospho-ERK profiling |
| JUN | Cancer, apoptosis | Overexpression of JUN in fibroblasts; AP-1 reporter assays |
Cancer
Dysregulated positive regulation of protein kinase activity is a hallmark of many cancers. Hyperactivation of MAPK pathways drives uncontrolled proliferation, and the ubiquitin-proteasome system can exacerbate this by stabilizing oncogenic kinases. NME7 kinase activity promotes Wnt/beta-catenin signaling and one-carbon metabolism in hepatocellular carcinoma, supporting tumor growth. AP-1 transcription factors, downstream of MAPK, influence cell life and death decisions and are implicated in tumorigenesis. Targeting the mechanisms that positively regulate kinase activity is therefore a promising therapeutic strategy.
Metabolic Disorders
AMPK is a key regulator of energy homeostasis, and its positive regulation by upstream kinases and subunits is critical for insulin sensitivity and glucose uptake. Metformin, a first-line drug for type 2 diabetes, acts in part by activating AMPK-dependent pathways. Impaired AMPK regulation contributes to insulin resistance and metabolic syndrome. Understanding how AMPK activity is positively regulated can inform new treatments for metabolic diseases.
Neurological and Inflammatory Diseases
Protein kinases such as mTOR and MAPK are involved in neuronal signaling, and their dysregulation has been linked to neurodegeneration and neuroinflammation. Lactylation of mTOR enhances autophagy in skeletal muscle during exercise, suggesting that similar mechanisms may operate in neurons. AP-1 factors regulate inflammatory gene expression and can contribute to chronic inflammation. Modulating positive regulation of kinase activity may offer therapeutic avenues for these conditions.
From positive regulation of protein kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of AMPK activation affect insulin sensitivity? | Knockout of PRKAA1/2 in mouse myoblasts or hepatocytes |
| Does lactylation of mTOR enhance autophagy? | Knock-in of lactylation-mimetic or -deficient mTOR in C2C12 myotubes |
| Is NME7 kinase activity required for Wnt/beta-catenin signaling? | Point mutation of NME7 catalytic residue in hepatocellular carcinoma cells |
| How does McsA regulate McsB kinase activity? | Knockout of mcsA in Bacillus subtilis; structural and biochemical assays |
| What is the role of ubiquitin-proteasome in MAPK signaling? | Overexpression of ubiquitin mutants or proteasome inhibitors in HEK293 cells |
| Does AP-1 feedback regulate kinase expression? | Knock-in of tagged JUN for ChIP-seq; overexpression of FOS |
How to Study the positive regulation of protein kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global changes in protein phosphorylation | Mapping signaling networks downstream of kinase activation |
| In vitro kinase assay | Direct catalytic activity of a kinase | Testing effects of mutations or subunits on AMPK activity |
| CRISPR knockout screen | Genes required for kinase activation | Identifying positive regulators of MAPK signaling |
| FRET biosensor imaging | Real-time kinase activity in live cells | Visualizing mTOR activation during exercise |
| Western blot with phospho-specific antibodies | Phosphorylation status of specific kinases | Confirming AMPK activation by metformin |
| Co-immunoprecipitation | Protein-protein interactions | Detecting McsB-McsA complex formation |
| Luciferase reporter assay | Transcriptional output of kinase pathways | Measuring Wnt/beta-catenin activation by NME7 |
| Ubiquitination assays | Ubiquitin conjugation to target proteins | Studying proteasomal regulation of MAPK components |
Phosphoproteomics
Phosphoproteomics allows global profiling of phosphorylation events that result from positive regulation of protein kinase activity. By comparing cells with and without a specific kinase activator or inhibitor, researchers can identify downstream substrates and quantify changes in kinase activity. This method is particularly useful for mapping signaling networks involving MAPK and AMPK.
Kinase Activity Assays
In vitro kinase assays using recombinant kinases and specific substrates measure the direct catalytic activity of a kinase. These assays can be coupled with mutagenesis to test the effect of point mutations or post-translational modifications on kinase activity. For example, AMPK activity can be measured using synthetic peptides or protein substrates in the presence of its regulatory subunits.
CRISPR Screens
Genome-wide CRISPR knockout or activation screens can identify genes that positively regulate a specific kinase activity. By using a reporter of kinase activity, such as a phosphorylation-dependent fluorescent biosensor, researchers can isolate regulators of the pathway. This approach is powerful for discovering novel components of positive regulation of protein kinase activity.
Live-cell Imaging
Genetically encoded FRET-based biosensors can monitor kinase activity in real time in living cells. These sensors undergo conformational changes upon phosphorylation, allowing spatiotemporal tracking of positive regulation events. Imaging can reveal where and when kinases are activated in response to stimuli.
How CRISPR Can Be Used to Study GO:0045860 positive regulation of protein kinase activity
Knockout
CRISPR knockout is used to completely eliminate a gene encoding a kinase or its regulator, allowing researchers to determine whether it is required for positive regulation of protein kinase activity. For example, knocking out PRKAA1 and PRKAA2 eliminates AMPK catalytic activity, enabling studies of downstream metabolic effects. Knockout of NME7 in hepatocellular carcinoma cells can test its role in Wnt/beta-catenin signaling.
Point Mutation
Point mutations can be introduced to specifically abrogate or mimic phosphorylation sites, catalytic residues, or regulatory modifications. For instance, mutating the lactylation site on mTOR can reveal whether this modification is necessary for enhanced autophagy during exercise. Similarly, point mutations in AMPK subunits can dissect the roles of individual domains in kinase regulation.
Knock-in
Knock-in of tagged or reporter versions of kinases allows for precise tracking of protein expression, localization, and interactions. A knock-in of GFP-tagged AMPK can be used to monitor its subcellular distribution upon activation. Knock-in of a luciferase reporter downstream of a kinase-responsive promoter can quantify pathway activity.
Overexpression
Overexpression of a wild-type or constitutively active kinase can amplify positive regulation and reveal downstream effects. Overexpressing NME7 in liver cells enhances Wnt/beta-catenin signaling and one-carbon metabolism. Overexpression of AP-1 components such as JUN and FOS can drive proliferation or apoptosis depending on context.
How EDITGENE Supports positive regulation of protein kinase activity Research
Researchers studying positive regulation of protein kinase activity-related genes often need to determine whether a candidate gene is causally involved in activating a specific kinase, and CRISPR-based cell models provide the most direct way to test this. By combining knockout, point mutation, knock-in, and overexpression strategies, it is possible to dissect the precise molecular mechanisms that enhance kinase activity and to validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein kinase activity research.
Frequently Asked Questions About positive regulation of protein kinase activity
What is GO:0045860 positive regulation of protein kinase activity?
GO:0045860 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate, or extent of protein kinase activity.
What genes are involved in positive regulation of protein kinase activity?
Key genes include AMPK subunits (PRKAA1, PRKAA2, PRKAB1, PRKAG1), MAPK1/3, MTOR, NME7, and AP-1 components JUN and FOS, among others.
How is protein kinase activity positively regulated?
It can be positively regulated by phosphorylation, subunit assembly, ubiquitin-proteasome remodeling, metabolite-driven modifications like lactylation, and scaffolding.
What diseases are associated with dysregulated positive regulation of protein kinase activity?
Cancer, metabolic disorders such as type 2 diabetes, and neurological or inflammatory diseases are linked to dysregulation of this process.
How can I study positive regulation of protein kinase activity in the lab?
Common methods include phosphoproteomics, in vitro kinase assays, CRISPR screens, FRET biosensors, and Western blotting with phospho-specific antibodies.
What is the role of AMPK in positive regulation of protein kinase activity?
AMPK is a key kinase whose activity is positively regulated by its beta and gamma subunits and upstream kinases like LKB1, especially under energy stress.
How does mTOR lactylation affect kinase activity?
Lactylation of mTOR enhances its activity and promotes autophagy in skeletal muscle during exercise, representing a metabolite-driven positive regulation.
Can CRISPR be used to study positive regulation of protein kinase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the mechanisms and consequences of kinase activation.
What is the difference between protein kinase activity and positive regulation of protein kinase activity?
Protein kinase activity is the molecular function of phosphorylating substrates, while positive regulation of protein kinase activity is the biological process that increases that function.
Where can I find CRISPR cell models for studying positive regulation of protein kinase activity?
EDITGENE provides custom CRISPR knockout, point mutation, knock-in, overexpression, and library screening services for genes involved in this process.
Conclusion
Positive regulation of protein kinase activity (GO:0045860) is a fundamental biological process that integrates diverse signals to control kinase function. Its mechanisms range from post-translational modifications and subunit assembly to ubiquitin-proteasome remodeling and metabolite-driven lactylation. Dysregulation of this process underlies major human diseases, including cancer and metabolic disorders, making it a prime target for therapeutic intervention. By leveraging CRISPR-based cell models and advanced screening technologies, researchers can dissect the causal roles of individual genes and identify new drug targets. EDITGENE offers comprehensive services to accelerate these discoveries.
References
- 1. Shaulian E et al.. 2002. AP-1 as a regulator of cell life and death.. Nat Cell Biol 4(5):E131-6 PMID: 11988758
- 2. Li Y et al.. 2025. Lactylation of mTOR enhances autophagy in skeletal muscle during exercise.. Cell Chem Biol 32(11):1367-1380.e5 PMID: 41223856
- 3. Hasanvand A. 2022. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.. Inflammopharmacology 30(3):775-788 PMID: 35419709
- 4. Dyck JR et al.. 1996. Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits.. J Biol Chem 271(30):17798-803 PMID: 8663446
- 5. Arifuzzaman M et al.. 2024. Structural insights into the regulation of protein-arginine kinase McsB by McsA.. Proc Natl Acad Sci U S A 121(17):e2320312121 PMID: 38625935
- 6. Mathien S et al.. 2021. Regulation of Mitogen-Activated Protein Kinase Signaling Pathways by the Ubiquitin-Proteasome System and Its Pharmacological Potential.. Pharmacol Rev 73(4):263-296 PMID: 34732541
- 7. Kjøbsted R et al.. 2016. Role of AMP-Activated Protein Kinase for Regulating Post-exercise Insulin Sensitivity.. Exp Suppl 107:81-126 PMID: 27812978
- 8. Ren X et al.. 2022. The Protein Kinase Activity of NME7 Activates Wnt/β-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma.. Cancer Res 82(1):60-74 PMID: 34764205
